By Matt Fair ( July 12, 2016, 5:48 PM EDT) -- Two generic-drug makers urged the Third Circuit during oral arguments on Tuesday to find that size mattered when it came to a judge's decision to certify a class of purchasers, totaling only about 20 companies, challenging pay-for-delay deals with Cephalon Inc. to keep off-brand versions of the narcolepsy medication Provigil off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.